Status:
COMPLETED
Prophylactic Ketorolac Post Epiretinal Membrane Surgery
Lead Sponsor:
Queen's University
Conditions:
Macular Edema
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Evaluate the efficacy of ketorolac 0.5%, a topical non-steroidal anti-inflammatory drug (NSAID), to prevent macular edema after epiretinal membrane surgery. Patients undergoing epiretinal membrane sur...
Eligibility Criteria
Inclusion
- idiopathic epiretinal membrane diagnosis requiring membrane peel surgery
Exclusion
- proliferative diabetic retinopathy
- sickle cell retinopathy
- radiation retinopathy
- choroidal folds
- hypersensitivity or allergy to NSAIDs
- wet macular degeneration
- branch retinal vein occlusion (BRVO)
- central retinal vein occlusion (CRVO)
- complicated membrane peel surgery
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00974753
Start Date
March 1 2010
End Date
March 1 2012
Last Update
January 13 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Hotel Dieu Hospital, Queen's University
Kingston, Ontario, Canada, K7L 3N6